Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations — Stella

Recruiting

Back to Lymphatic Malformation trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

France

Hôpital Jeanne de Flandres, CHU, Lille

Hu Robert Debre Aphp - Paris, Paris

Key details

Phase

Safety & dosing

Sponsor

University Hospital, Lille

Collaborators

Ministry of Health, France

Enrollment target

~28 participants

Started

June 2018

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov